Fda Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
U.S. Newswire › November 21, 2008
Linked as:
Summary
To: NATIONAL EDITORS
Contact: Media: Greg Panico, +1-908-927-3715, +1-908-240-2011; Investor Relations: Louise Mehrotra, +1-732-524-6491 or Lesley Fishman, +1-732-524-3922, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.See the full content of this document
Extract
Fda Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
RARITAN, N.J., Nov. 21 /PRNewswire/ -- Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option. Today, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD), announced that the U.S. Food and Drug Administration (FDA) approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults 18 years of age or older.
Tapentadol is a new centrally acting oral analgesic. It ha...See the full content of this document
Sponsored links
